CUSIP M74240108ORDINARY SHARESQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
13 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Yorkville Advisors Global, LP | 100.0K | $76.9K | +100.0K | New |
| 2 | Two Sigma Investments, LP | 51.5K | $39.6K | +30.5K | Added |
| 3 | Meitav Investment House Ltd | 40.0K | $30.8K | 0 | Held |
| 4 | Gts Securities LLC | 35.8K | $27.5K |
| +35.8K |
| New |
| 5 | Ubs Group AG | 30.9K | $23.7K | +16.2K | Added |
| 6 | Commonwealth Equity Services, LLC | 22.8K | $17.5K | +1.7K | Added |
| 7 | Squarepoint Ops LLC | 17.9K | $13.8K | −77.4K | Reduced |
| 8 | Pathstone Holdings, LLC | 16.5K | $12.7K | +16.5K | New |
| 9 | Geode Capital Management, LLC | 15.9K | $12.2K | 0 | Held |
| 10 | Creative Planning | 11.9K | $9.2K | +11.9K | New |
See every fund holding Neurosense Therapeutics Ltd, with full quarter-over-quarter share changes.
Unlock all holders